Civil rights, medical groups sue FDA over ‘almost unconscionable’ delay in ban on menthol tobacco products

Civil rights and medical groups are suing the FDA for missing its deadline to ban menthol cigarettes. Delay in action prioritizes profits over people, impacting health disparities within Black and LGBTQ+ communities. The FDA's ban on menthol could save lives and reduce healthcare costs, especially benefiting these marginalized groups. Studies show significant health impacts, with menthol marketing affecting smoking rates and related illnesses disproportionately among Black individuals. Implementing a menthol ban is crucial for public health, aligning with cancer prevention goals and potentially reducing lung cancer deaths.